S
Skye Bioscience, Inc. (SKYE)
NGM – Real Time Price. Currency in USD
0.81
-0.07 (-7.56%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
0.81
-0.07 (-7.56%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $5.9M significantly exceed its total debt $273.6K, ensuring strong financial flexibility
Total current assets $27.1M exceed Total current liabilities $8.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$9.8M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.30 | 6.05 | 10 | |
| Quick ratio | 3.30 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 9.0 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -115K | -124K | -299K | -723K | -723K |
| Operating Income | -12M | -14M | -36M | -58M | -58M |
| Net Income | -19M | -38M | -27M | -56M | -56M |
| EBITDA | -12M | -14M | -36M | -57M | -57M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -10.19 | 1.0 |
| Next quarter | N/A | 44.54 | 5.5 |
| Current year | N/A | 31.83 | 5.5 |
| Next year | N/A | -17.53 | 1.0 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -13.22 | -12.49 | 26.92 | 5.5 |
| Y/Y | 999 | -48.17 | -49.99 | -18.76 | 3.3 |
| 3y average | 999 | -58.08 | -3.36 | -53.98 | 3.3 |
| 5y average | 999 | -66.54 | N/A | -52.95 | 3.3 |
| Weighted average score | 3.9 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |